Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

14.81
Delayed Data
As of Sep 02
 +0.47 / +3.28%
Today’s Change
11.93
Today|||52-Week Range
32.82
-18.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues9.3M11.2M4.1M3.6M
 
 
 
 
 
Cost of Goods Sold6.9M8.7M2.3M0.00
 
 
 
 
Depreciation And Amortization4.2M3.1M2.9M3.4M
 
 
 
 
 
 
Operating ExpensesGross Income-1.8M-663.0K-1.2M185.0K
 
 
 
 
 
General Expenses41.7M57.4M80.3M122.6M
 
 
 
 
 
Research And Development32.4M47.4M65.5M102.0M
 
 
 
 
 
Total Operating Expenses52.7M69.3M85.6M126.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.4M-58.1M-81.4M-122.4M
 
 
 
 
 
Interest Expense On Debt1.8M1.6M927.0K0.00
 
 
 
 
Other Expenses50.0K100.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.8M-59.1M-81.6M-118.1M
 
 
 
 
 
Net Income-44.8M-59.1M-81.6M-118.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.5M57.7M79.8M89.4M
 
 
 
 
 
Shares To Calculate EPS Diluted39.5M57.7M79.8M89.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.13-$1.02-$1.02-$1.32
 
 
 
 
 
EPS Diluted-$1.13-$1.02-$1.02-$1.32